F
$ Value
$224K
Shares
12,674
Price
$18
Filed
Mar 10
Insider
Name
Rasul Reazur
Title
EVP,Group Pres,Healthcare
CIK
0001967379
Roles
Officer
Transaction Details
Transaction Date
2026-03-06
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
125,557
Footnotes
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.
Filing Info
Rasul Reazur's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-06 | BAX | F | $224K |
| 2026-03-02 | BAX | F | $32K |
| 2026-02-09 | BAX | A | $0 |
| 2026-02-09 | BAX | F | $125K |
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-03-06 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-03-06 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-06 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-02 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-06 |